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Abstract 55 
Hepatitis B virus (HBV) is a major cause of human hepatitis. There is 56 
considerable uncertainty about the timescale of its evolution and its association 57 
with humans. Here we present 12 full or partial ancient HBV genomes between 58 
~0.8-4.5 thousand years old. The ancient sequences group either within or in 59 
sister relationship to extant human or other ape HBV clades. Generally, the 60 
genome properties follow those of modern HBV. The root of the HBV tree is 61 
projected to between 8.6-20.9 thousand years ago (kya), and estimate a 62 
substitution rate between 8.04x10-6-1.51x10-5 nucleotide substitutions per site per 63 
year (s/s/y). In several cases, the geographic locations of the ancient genotypes do 64 
not match present day distributions. Genotypes that today are typical of Africa 65 
and Asia, and a subgenotype from India, are shown to have an early Eurasian 66 
presence. The geographic and temporal patterns we observe in ancient and 67 
modern HBV genotypes are compatible with well-documented human 68 
migrations during the Bronze and Iron Ages1,2. We show evidence for the 69 
creation of genotype A via recombination and a long-term association of modern 70 
HBV genotypes with humans, including the discovery of a human genotype that 71 
is now extinct. Taken together, the data expose a complexity of HBV evolution 72 
that is not evident when considering modern sequences alone. 73 
 74 
HBV is transmitted perinatally or horizontally via blood or genital fluids3. The 75 
estimated global prevalence is 3.6%, ranging from 0.01% (UK) to 22.38% (South 76 
Sudan)4. In high endemicity areas, where prevalence is > 8%, 70-90% of the adult 77 
population show evidence of past or present infection5,6. The young and the 78 
immunocompromised are most likely to develop chronic HBV infection, which can 79 
result in high viremia over years to decades3. Approximately 257 million people are 80 
chronically infected5 and around 887,000 died in 2015 due to associated 81 
complications5.  82 
 83 
Despite the prevalence and public health impact of HBV, its origin and evolution 84 
remain unclear7,8. Inference of HBV nucleotide substitution rates is complicated by 85 
the fact that the virus genome consists of four overlapping open reading frames9, and 86 
mutation rates differ between phases of chronic infection10. Studies based on 87 
heterochronous sequences, sampled over a relatively short time period, find higher 88 
substitution rates, whereas rates estimated using external calibrations tend to be lower, 89 
leading to a wide range of estimated substitution rates (7.72x10-4-3.7x10-6) for HBV11-90 
13. Human HBV is classified into at least nine genotypes, A-I, roughly corresponding 91 
to sequence similarity of at least 92.5% within genotypes14, with a heterogeneous 92 
global distribution (Fig. 1a)8,9. Attempts to explain the origin of genotypes using 93 
human migrations have been inconclusive. The hypothesis that HBV co-evolved with 94 
ancient modern humans as they left Africa has been contested due to the basal 95 
phylogenetic position of genotypes F and H, found exclusively in the Americas7. 96 
HBV also infects non-human primates (NHP), and the human and other great ape 97 
HBV are interspersed in the phylogenetic tree, possibly due to cross-species 98 
transmission15. Given the variability of estimated substitution rates, the incongruence 99 
of the tree topology with some human migrations, and the mixed topology of the NHP 100 
and human HBV sequences in the phylogenetic tree, considerable uncertainty remains 101 
about the evolutionary history of HBV. 102 
 103 
Recent advances in the sequencing of ancient DNA (aDNA) have yielded important 104 
insights into human evolution, past population dynamics16, and diseases17,18. 105 
However, ancient sequences have been recovered for only a handful of exogenous 106 
human viruses, including influenza (~100 years)19, variola (~350 years)20, and HBV 107 
(~340 years and ~450 years)21,22. The knowledge gained from these few cases 108 
emphasizes the general importance of ancient sequences for the direct study of long-109 
term viral evolution. HBV has several characteristics that make it a good candidate for 110 
detection in an aDNA virus study: its extended high viremia during chronicity3, the 111 
relative stability of its virion23, and its small, circular, and partially double-stranded 112 
DNA genome9. 113 
  114 
Shotgun sequence data were generated from 167 Bronze Age1 and 137 predominantly 115 
Iron Age2 individuals from Central to Western Eurasia with a sample age range of 116 
~7.1-0.2 kya. We identified reads that matched the HBV genome in 25 samples 117 
(Table 1, Extended Data Table 1a, SI Table 3), spanning a period of almost 4000 118 
years, from several different cultures and a broad geographical range (Fig. 1b, Table 119 
1, Extended Data Table 1a, SI Table 3). Using TaqMan PCR, we tested two samples 120 
with high genome coverage (DA195, DA222) and two samples with low coverage 121 
(DA85, DA89) for the presence of HBV. The high-coverage samples tested positive, 122 
whereas the low-coverage samples tested negative (Extended Data Table 1b). This is 123 
consistent with shotgun sequencing being more effective than targeted PCR for 124 
analysing highly degraded DNA24. Based on availability of sample material, libraries 125 
from 14 samples were selected for targeted enrichment (capture) of HBV DNA 126 
fragments (SI Tables 1 and 2). This resulted in increased genome coverage and an 127 
average of a 2.4-fold increase in number of HBV positive reads (Extended Data Table 128 
1a, SI Table 3). In total, we obtained 17.9 to 100% HBV genome coverage from the 129 
sequence data, with genomic depth ranging from 0.4x to 89.2x (Table 1, Extended 130 
Data Table 1a). We selected 12 samples for phylogenetic analyses. Criteria for 131 
inclusion were at least 50% genome coverage and clear aDNA damage patterns after 132 
capture (Extended Data Fig. 1). 133 
  134 
For an initial phylogenetic grouping, we estimated a Maximum Likelihood (ML) tree 135 
using the ancient HBV genomes together with modern human, NHP, rodent, and bat 136 
HBV genomes (Dataset 1, see Methods). All ancient viruses fell within the diversity 137 
of Old World primate HBV genotypes, which includes all human and other great ape 138 
genotypes, except human genotypes F and H (Extended Data Fig. 2). 139 
  140 
Recombination is known to occur in HBV25. We found strong evidence that an 141 
ancient sequence, HBV-DA51, and an unknown parent recombined to form the 142 
ancient genotype A sequences. Although that cannot literally be the case due to 143 
sample ages, the logical interpretation is that an ancestor of HBV-DA51 was involved 144 
in the recombination. The same recombination is also suggested for the two modern 145 
genotype A sequences that were included in the analysis. The ancient genotype B 146 
(HBV-DA45), a modern genotype B, and two modern genotype C sequences were not 147 
similarly flagged, suggesting that the possible recombination occurred after genotypes 148 
A, B, and C had diverged. The predicted recombination break points (Extended Data 149 
Table 2, Extended Data Fig. 3) correspond closely to the polymerase gene. Thus, it is 150 
possible that the polymerase from an unknown parent and the remainder of the 151 
genome from an HBV-DA51 ancestor recombined to form the now ubiquitous 152 
genotype A about 7.4-9 kya (Fig. 2, Extended Data Table 3b, Methods). Similar 153 
recombinations events, involving the creation of genotypes E and G and a currently 154 
circulating B/C recombinant, have also been identified25. 155 
 156 
For detailed phylogenetic analyses, we used a set of 112 reference human and NHP 157 
HBV sequences (Dataset 2, see Methods). An ML phylogenetic tree based on these 158 
reference sequences and all ancient sequences was constructed (Extended Data Fig. 159 
4). Regression of root-to-tip genetic distances against sampling dates, as well as date 160 
randomisation tests, showed a clear temporal signal in the data (Extended Data Fig. 5, 161 
SI Figs. 1-3), suggesting that molecular clock models can be applied. A dated 162 
coalescent phylogeny was constructed using BEAST226 (Fig. 2). The molecular clock 163 
was calibrated using tip dates. Strict and relaxed lognormal molecular clocks were 164 
tested with coalescent constant, exponential, and Bayesian skyline population priors 165 
(Extended Data Table 3a). Model comparisons favoured a relaxed molecular clock 166 
model with lognormally distributed rate variation and a coalescent exponential 167 
population prior (Extended Data Table 3a). The median root age of the resulting tree 168 
is estimated to 11.6 kya (95% Highest Posterior Density (HPD) interval: 8.6 to 15.3 169 
kya) and the median clock rate is 1.18x10-5 s/s/y (95% HPD interval: 9.21x10-6 to 170 
1.45x10-5 s/s/y). Under a strict molecular clock, a coalescent Bayesian skyline 171 
population prior was favoured, in which case the median root age is 15.6 kya (95% 172 
HPD interval: 13.7 to 17.8 kya) and the median substitution rate 9.48x10-6 s/s/y (95% 173 
HPD interval: 8.3x10-6 to 1.07x10-5 s/s/y) (Extended Data Tables 3a-c).  174 
 175 
Under all model parameterisations used here, the substitution rate we find is lower 176 
than rates estimated from phylogenies built using either modern heterochronous 177 
sequences11 or sequences from mother-to-child transmissions27, but higher than rates 178 
inferred using external calibrations based on human migrations12. A lower rate is 179 
consistent with Tedder et al. (2013)28, who found that although mutation rates may be 180 
high, mutations within an individual often revert back to the genotype consensus, and 181 
thus rarely lead to long-term sequence change. It is also consistent with the so-called 182 
time-dependent rate phenomenon, observed for many viruses, which shows that short-183 
term evolutionary rates are higher than long-term rates29. 184 
 185 
The knowledge of ancient HBV genomes enables us to formally evaluate hypotheses 186 
concerning HBV origins using path sampling of calibrated phylogenies based on 187 
appropriate external divergence date assumptions. We tested several calibration points 188 
implied by a co-expansion of HBV with humans after leaving Africa for support of 189 
congruence between migrations and geographical locations of HBV clades12. We find 190 
weak evidence for a split of the F/H clade between 13.4 and 25.0 kya under a strict, 191 
but not a relaxed clock model. We do not find support for the divergence of 192 
subgenotype C3 strains between 5.1-12.0 kya, leading to a distribution in different 193 
regions of Polynesia, or for divergence of Haitian A3 strains from other genotype A 194 
strains between 0.2-0.5 kya under either strict or relaxed clock models (Extended Data 195 
Table 3d).  196 
 197 
In the dated coalescent phylogeny, four ancient sequences (from youngest to oldest: 198 
HBV-DA119, -DA195, -RISE386, and -RISE387) group with genotype A. The first 199 
three fall well within the 7.5% nucleotide divergence criterion used to delimit 200 
membership in HBV genotypes. HBV-RISE387 is right on this limit (Extended Data 201 
Table 4a)14. The three oldest samples lack a six nucleotide insertion at the carboxyl 202 
end of the Core gene that is present in all modern genotype A viruses (Table 2)9. 203 
HBV-RISE387 encodes a stop codon in its pre-Core peptide that would have ablated 204 
the expression of the immune modulator HBe antigen (HBeAg), a phenomenon 205 
known in modern HBV infections (Table 2). This characteristic viral mutant is usually 206 
found in chronic HBV carriers who seroconverted from HBeAg to anti-HBe. 207 
Interestingly, RISE386 and RISE387 are archaeologically dated only ~100 years apart 208 
and both come from the Bulanovo site in Russia, but their viruses show only 93.34% 209 
sequence identity (Extended Data Table 4b), indicating the existence of significant 210 
localized HBV diversity ~4.2 kya. 211 
 212 
The ancient sequence HBV-DA45 phylogenetically groups with genotype B and has 213 
97.65% sequence identity with modern genotype B (Extended Data Table 4a). 214 
 215 
Sequences HBV-DA51, -DA27, -DA222, and -DA29 phylogenetically group with the 216 
modern genotype D. They have high sequence identity (96.99 to 98.74%) with 217 
modern genotype D sequences (Extended Data Table 4a), and have the typical 33 218 
nucleotide deletion in the PreS1 sequence of the S-gene, encoding the three HBV 219 
surface proteins9 (Table 2). 220 
 221 
Sequences HBV-RISE154, -RISE254, and -RISE563 are in sister relationship to the 222 
Chimpanzee/Gorilla HBV clade (Fig. 2). HBV-RISE254 and -RISE563 have the same 223 
33 nucleotide deletion in the PreS1 sequence that is shared with NHP HBV and 224 
human genotype D (Table 2). HBV-RISE563 does not encode a functional pre-Core 225 
peptide (Table 2). Based on sequence similarity across the whole genome, HBV-226 
RISE563 and -RISE254 together might be classified as a new human genotype that is 227 
extinct today, and HBV-RISE154 as possibly another (Extended Data Table 4). 228 
However, HBV-RISE154 has low genome coverage, which precludes an exact 229 
calculation. The sister relationship of these three sequences with modern Chimpanzee 230 
and Gorilla HBV could be interpreted as a consequence of relatively recent 231 
transmission(s) of HBV from humans to NHPs15. However, other scenarios and 232 
confounding factors are possible, as these lineages are deeply separated in the tree. 233 
Incomplete lineage sorting combined with viral extinction (possibly boosted by 234 
massive recent reductions in great ape populations) should be considered. More data 235 
on current and, if possible, ancient NHP-associated HBV will be necessary to reach 236 
definitive conclusions.  237 
 238 
The geographic locations of some of the ancient virus genotypes do not match the 239 
present-day genotype distribution, and also do not match dates and/or locations 240 
inferred in previous studies of HBV. While it is important to keep in mind that the 241 
data presented here are limited, they provide important spatiotemporal reference 242 
points in the evolutionary history of HBV. Their synopsis suggests a more 243 
complicated ancestry of present-day genotypes than previously assumed, especially in 244 
light of recent insights into the history of human migration.  245 
 246 
We find genotype A in South-Western Russia by 4.3 kya (RISE386, RISE387), in 247 
individuals belonging to the Sintashta culture and in a sample (DA195) from the 248 
Scythian culture. The western Scythians are related to the Bronze Age cultures of the 249 
Western Steppe populations2 and their shared ancestry suggests that the modern 250 
genotype A may descend from this ancient Eurasian diversity and not, as previously 251 
hypothesized, from African ancestors30,31. This is also consistent with the phylogeny 252 
(Fig. 2), as well as the fact that the three oldest ancient genotype A sequences (HBV-253 
DA195, -RISE386, and -RISE387) lack the six nucleotide insertion found in the 254 
youngest (HBV-DA119), and all modern genotype A sequences. The ancestors of 255 
subgenotypes A1 and A3 could have been carried into Africa subsequently, via 256 
migration from western Eurasia32. 257 
 258 
The ancient HBV genotype D sequences were all found in Central Asia. HBV-DA27, 259 
found in Kazakhstan and dated to 1.6 kya, falls basal to the modern subgenotype D5 260 
sequences that today are found in the Paharia tribe from eastern India33. DA27 and the 261 
Paharia people in India are linked by their Tibeto-Burman ancestry2,34, possibly 262 
explaining the similar viruses.  263 
 264 
Based on the observation that genotypes go extinct and can be created by 265 
recombination, our data show that the diversity we observe today is only a subset of 266 
the diversity that has ever existed. Our data support a scenario in which all present 267 
day HBV diversity arose only after the split of the Old World and New World 268 
genotypes (25-13.4 kya).  Any attempt to interpret the currently known HBV tree 269 
based on human migrations that happened before this event will necessarily result in 270 
anomalies that cannot be reconciled, such as the basal position of genotypes F/H and 271 
the apical position of subgenotype C4, which is exclusively found in indigenous 272 
Australians9. If HBV did co-evolve with ancient modern humans as they left Africa as 273 
proposed previously7, most of the pattern of earlier diversity has been replaced by 274 
changes that happened after the split of the Old and New World genotypes. Genotypes 275 
F and H would therefore be remnants of the earlier now-extinct diversity, and the 276 
arrival of subgenotype C4 in Australia would have taken place long after the Old/New 277 
World split, as supported by our tree in Figure 2. Alternatively, there could have been 278 
a New World origin of HBV or the introduction of HBV into humans from a different 279 
host. Our data do not allow us to speculate either way. 280 
 281 
To our knowledge, we report the oldest exogenous viral sequences recovered from 282 
DNA of humans or any vertebrate. We show for the first time that is possible to 283 
recover viral sequences from samples of this age. We show that humans throughout 284 
Eurasia were widely infected with HBV for thousands of years. Despite the age of the 285 
samples and the imperfect diagnostic test, our dataset contained a surprisingly high 286 
proportion of HBV-positive individuals. The actual ancient prevalence during the 287 
Bronze Age and thereafter might have been higher, reaching or exceeding the 288 
prevalence typically found in contemporary indigenous populations6. This clearly 289 
establishes the potential of HBV as powerful proxy tool for research into human 290 
spread and interactions. The ancient data reveal aspects of complexity in HBV 291 
evolution that are not apparent when only modern sequences are considered. They 292 
show the existence of ancient HBV genotypes in locations incongruent with their 293 
present-day distribution, contradicting previously suggested geographic or temporal 294 
origins of genotypes or sub-genotypes; evidence for the creation of genotype A via 295 
recombination and the emergence of the genotype outside Africa; at least one now-296 
extinct human genotype; ancient genotype-level localized diversity; and demonstrate 297 
that the viral substitution rate obtained from modern heterochronously sampled 298 
sequences is misleading. These suggest that the difficulty in formulating a coherent 299 
theory for the origin and spread of HBV may be due to genetic evidence of an earlier 300 
evolutionary scenario being overwritten by relatively recent alterations, as also 301 
suggested by Simmonds et al., in the context of recombination25. The lack of ancient 302 
sequences limits our understanding of the evolution of HBV and, very likely, of other 303 
viruses. Discovery of additional ancient viral sequences may provide a clearer picture 304 
of the true origin and early diversification of HBV, enable us to address questions of 305 
paleo-epidemiology, and broaden our understanding of the contributions of natural 306 
and cultural changes (including migrations and medical practices) to human disease 307 
burden and mortality.  308 
 309 
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Tables 449 
  450 
Table 1: Overview of samples used for phylogenetic analyses 451 
Sample 14C age 
(standard 
deviation) 
Median cal 
BP age, or 
estimate 
(years) 
Approx. 
sample age 
(years) 
Site Culture or 
period 
Sex Reads 
included in 
consensus 
Coverage 
Consensus Depth 
RISE563 3955 (35) 4421 4488 Osterhofen-
Altenmarkt, Germany 
Bell 
Beaker 
M 4383 100% 79.3x 
DA222 N/D 1200-1000 1167 Butakty, Kazakhstan Karluk M 4132 100% 89.2x 
DA195 2479 (35) 2578 2645 Sandorfalva-Eperjes, 
Hungary 
Hungarian 
Scythian 
F 1445 99.9% 29.2x 
DA51 2220 (37) 2230 2297 Keden, Kyrgyzstan Saka M 712 99.2% 14.5x 
RISE254 3631 (29) 3942 4009 Szàzhalombatta-
Földvàr, Hungary 
Vatya M 1491 99.0% 36.6x 
DA119 N/D 1500 1567 Poprad, Slovakia North 
Carpathian 
M 2597 98.8% 53.1x 
RISE386 3758 (34) 4121 4188 Bulanovo, Russia Sintashta M 331 97.8% 7.0x 
DA27 1641 (33) 1543 1610 Halvay 3, Kazakhstan Hun-
Sarmatian 
M 890 90.0% 14.3x 
DA29 849 (25) 755 822 Karasyur, Kazakhstan Medieval M 222 87.5% 4.8x 
DA45 2083 (27) 2053 2120 Omnogobi, Mongolia Xiongnu M 215 87.2% 4.3x 
RISE387 3822 (33) 4215 4282 Bulanovo, Russia Sintashta N/
D 
284 86.6% 6.2x 
RISE154 3522 (24) 3784 3851 Szczepankowice, 
Poland 
Unetice F 128 57.2% 2.0x 
Samples included in phylogenetic analysis, by decreasing genome coverage. Criteria for inclusion were at least 452 
50% genome coverage and sufficient aDNA damage patterns after capture. The read count indicates the number 453 
of reads used to make consensus sequences. N/D (not determined) indicates samples where dating was not 454 
performed or where osteological sex was undetermined. See Methods for information on sequence matching, 455 
consensus making, and sample dating. 456 
  457 
Table 2: Genome properties of ancient sequences included in phylogenetic analyses 458 
Sample Genotype 
of closest 
sequence 
Sequence 
identity to 
closest 
sequence 
Genome 
length 
Sero-
type 
Insertions / deletions Predicted HBeAg 
status 
DA119 A3 97.8% 3221 adw2 6nt insert at the C-terminus of 
core region 
Positive 
DA195 A3 96.2% 3215 adw2 None Positive 
RISE386 A 95.2% 3215 adw2 None Positive 
RISE387 A 
  
92.5% 3215 adw2 None Negative 
PreC stop codon 
DA45 B1 96.6% 3215 ayw1 None Positive 
DA29 D3 
  
98.5% 3182 ayw2 33nt deletion at the N-
terminus of the preS1 region 
Positive 
 
DA222 D3 
  
98.7% 
  
3182 ayw2 33nt deletion at the N-
terminus of the preS1 region 
Positive 
  
DA27 D1 
  
97.2% 
  
3182 ayw2 33nt deletion at the N- 
terminus of the preS1 region 
Positive 
  
DA51 D1 
  
96.7% 
  
3182 ayw2 33nt deletion at the N- 
terminus of the preS1 region 
Positive 
  
RISE154 Chimp. 92.5% Ambiguous adw2* Ambiguous Positive 
  
RISE254 Chimp. 95.2% 
  
3182 adw2 33nt deletion at the N- 
terminus of the preS1 region 
Positive 
  
RISE563 Gorilla 
  
92.7% 3182 adw2 33nt deletion at the N- 
terminus of the preS1 region 
Negative 
PreC stop codon 
Genotype groups are sorted by increasing sample age. * Serotype could not be determined unambiguously, due 459 
to lack of coverage. 460 
  461 
Figure legends 462 
Figure 1: Geographic distribution of analysed samples and modern genotypes 463 
a, Distribution of modern human HBV genotypes8. Genotypes relevant to the manuscript are shown in colour. 464 
Coloured shapes indicate the locations of the HBV-positive samples included for further analysis, as in panel b. 465 
b, Locations of analysed Bronze Age samples1 are shown as circles, Iron Age and later samples2, as triangles. 466 
Coloured markers indicate HBV-positive samples. Ancient genotype A samples are found in regions where 467 
genotype D predominates today, and DA27 is of sub-genotype D5 which today is found almost exclusively in 468 
India. 469 
 470 
Figure 2: Dated maximum clade credibility tree of HBV 471 
A lognormal relaxed clock and coalescent exponential population prior were used. Grey horizontal bars indicate 472 
the 95% HPD interval of the age of the node. Larger numbers on the nodes indicate the age and 95% HPD 473 
interval of the age under a strict clock and Bayesian skyline tree prior. Clades of genotypes C (except clade C4), 474 
F, and H are collapsed and shown as dots. Taxon names indicate: genotype / subgenotype, accession number, 475 
sample age, country abbreviation of sequence origin, region of sequence origin, host species, and optional 476 
additional remarks. 477 
  478 
Methods 479 
HBV datasets 480 
The following HBV datasets were used in the present study. Full listings of accession 481 
numbers are given in the Supplementary Methods. 482 
Dataset 1: 26 HBV genomes, covering all species in the Orthohepadnaviridae. This includes 483 
one sequence each from the human HBV genotypes (A-J), Orangutan, Chimpanzee, Gorilla, 484 
Gibbon, Woolly monkey, Woodchuck, Ground squirrel, Arctic ground squirrel, Horseshoe 485 
bat, and four sequences from Roundleaf bats and three from Tent-making bats, largely 486 
following Drexler et al.35 487 
Dataset 2: 124 HBV genomes, from humans and NHP. This set contains 92 sequences from 488 
Paraskevis et al.12 (excluding their incomplete sequences), 7 additional genotype D 489 
sequences, the Korean mummy genotype C sequence21, the 12 ancient sequences from the 490 
present study, and 12 full genomes selected from a set of 9066 full HBV genomes 491 
downloaded from NCBI36 on 2017-08-24 (Entrez query: hepatitis b virus[organism] not 492 
rna[title] not clone[title] not clonal[title] not patent[title] not recombinant[title] not 493 
recombination[title] and 3000:4000[sequence length]) corresponding to the closest, non-494 
artificial match for each of the ancient sequences. Dates for these sequences were acquired by 495 
looking for a date of sample collection in the NCBI entry, or the paper where the sequence 496 
was first published. If a range of dates was mentioned, the mean was used. If no date of 497 
sample collection was found in this way, either the year of the publication of the paper, or the 498 
year of addition of the sequence to GenBank was used, whichever was earlier. 499 
Dataset 3: 124 HBV genomes, from humans, NHP, and a variety of other Orthohepadnavirus 500 
host species, including Woolly monkey, Roundleaf and Tent-making bat, Ground and Arctic 501 
ground squirrel, Woodchuck, and Snow goose. This set contains 113 sequences that are the 502 
union of a selection of 91 sequences from Paraskevis et al.12 and 29 from Drexler et al.35, and 503 
11 additional sequences. 504 
Dataset 4: 3505 HBV genomes. 3384 are from Bell et al., (2016)37, divided into ten human 505 
genotypes. To these we added 17 Chimpanzee, 56 Gorilla, 12 Gibbon and 36 Orangutan full 506 
HBV genome sequences downloaded from NCBI on 2017-01-18, resulting in 14 genome 507 
categories. 508 
Dating of ancient samples 509 
Sample ages were determined by direct 14C-dating. These ages were calibrated using OxCal38 510 
(version 4.3) using the IntCal13 curve39. Table 1 shows the 14C age and standard deviation for 511 
each sample. This is followed by the median probability calibrated age before present (cal 512 
BP), where “present” is defined as 1950. RISE386 was 14C dated twice, with ages (standard 513 
deviation) of 3740 (33) and 3775 (34), so a rounded mean of 3758 (34) was used for its 514 
calibration. DA29 was dated at 822 years using 14C and also at ~700 years using multi-proxy 515 
methods, the former was used for consistency. The dates for DA119, DA222, RISE548, 516 
RISE556, RISE568, and RISE597 are best estimates, based on sample context. 517 
Data and data processing 518 
We analysed 101 Bronze Age samples published in Allentoft, et al.1, 137 predominantly Iron 519 
Age samples published in Damgaard et al.2, and 66 additional samples from the Bronze Age. 520 
A total of 114.58x109 Illumina HiSeq 2500 sequencing reads were processed. 521 
  522 
AdapterRemoval40 (version 2.1.7) was used with its default settings to remove adaptors from 523 
all sequences, to trim N bases from the ends of reads, and to trim bases with quality ≤ 2. 524 
Reads were aligned against a human genome (GRCh3841) using BWA42 (version 0.7.15-525 
r1140, mem algorithm). Reads that did not match the human genome were then mapped 526 
against the NCBI viral protein reference database containing 274,038 viral protein sequences 527 
(downloaded on 2016-08-31) using DIAMOND43 (version 0.8.25). Protein matches were 528 
grouped into their corresponding viruses. Reads matching HBV were found in 25 samples. 529 
  530 
The non-human reads from the HBV-positive samples that had more than three reads 531 
matching HBV using DIAMOND were selected for a subsequent BLAST44 (version 2.4.0) 532 
analysis. A BLAST database was made from Dataset 3, and samples were matched using 533 
blastn (with arguments -task blastn -evalue 0.01). Matching reads with bit scores greater than 534 
50 for all samples (except DA222 (70) and DA45 (55)) were selected for subsequent 535 
processing. The number of reads selected from the BLAST matches, per sample, is shown in 536 
Table 1, with additional detail in Extended Data Table 1. Across all samples 11,149 reads 537 
matched against HBV sequences. 538 
PCR confirmation 539 
Real-time PCR was established using primers and TaqMan probes as described by Drosten et 540 
al.,45 which amplifies a 91 base pair amplicon of the HBV genome. Primers and probe were 541 
added to QuantiTect PCR mix (Qiagen #204343) in a final concentration of 400 nM or 200 542 
nM, respectively, in a total reaction volume of 25 ul, including 5 ul template. Using the 543 
Roche LC480 or Agilent Mx3006p instruments, PCRs were incubated for 15 min. at 95°C 544 
followed by 45 cycles of 15 seconds at 94°C and 60 seconds at 60°C, measuring fluorescence 545 
from the 6-carboxy-fluorescein/BHQ1-labelled probe and the passive dye (ROX) at the end 546 
of each cycle. 547 
Careful precautions were taken to prevent PCR contamination. PCR mastermixes were 548 
prepared in dedicated ancient DNA clean lab facilities, in which no prior targeted work has 549 
been carried out on HBV. Ancient DNA extracts and non-template controls (NTC) were 550 
added into PCR reactions in this location too, which were not subsequently opened. Positive 551 
control material was handled in labs in a physically separated building. Here, standard 552 
material, diluted to 5-50 copies/reaction, was added to duplicate PCR reactions along with 553 
additional NTCs. 554 
Virus capture 555 
14 samples with sufficient sample material were selected for virus capture (DA27, DA29, 556 
DA45, DA51, DA85, DA89, DA119, DA195, DA222, RISE254, RISE386, RISE416, 557 
RISE568, RISE556). The viral reference genomes for probes were selected as follows. The 558 
International Committee for Taxonomy of Viruses (ICTV) 2012 listed 2618 viral species. As 559 
many had no associated reference genomes or merely partial sequence information, we 560 
selected 2599 sequences of full-length viral genomes, available from GenBank (June 2014), 561 
representing viral species found in vertebrates excluding fish. Sequences <1000 nt were 562 
discarded. Sequences with identical length and organism ID were regarded as duplicates and 563 
thus reduced to 1. For a number of specific viral taxa for which a large number of similar 564 
reference sequences are available, we manually selected representative genomes or genome 565 
segments (SI Tables 1 and 2). For example, among 72 available Hepatitis C virus genome 566 
sequences, we selected one genome per subtype (1a-c, g; 2a-c, i, k; 3a, b, i, k; 4a-d, f, g, k-r, 567 
t; 5a; 6a-u; 7a). Likewise, 12 HIV-1 genomes were selected representing groups M (subtypes 568 
A-D, F1, F2, H, J, K, N, O, and P). For influenza A virus, we included only sequences from 569 
segment 7 and segment 5 encoding the conserved matrix proteins M1/M2 and the 570 
nucleocapsid protein NP, respectively. We selected 82 M1/M2 segments and 115 NP 571 
segments among the available segments sequences. All available segments were included 572 
from genomes belonging to Arenaviridae, Bunyaviridae, and Reoviridae. For members of 573 
Poxvirinae for which full genomes were unavailable (Skunk-, Racoon-, and Volepox virus) 574 
sequences representing the conserved gene encoding the DNA-dependent RNA polymerase 575 
were included (n=22). In addition, 2 partial genomes of Squirrelpox virus were included. By 576 
mistake 2 and 9 partial sequences were included from Iridoviridae (1.5-2.5 kb) and 577 
Coronaviridae (1.3-14.5 kb), respectively, already represented by full genomes. Likewise, 578 
sequences representing Merkel cell polyomavirus and KI polyomavirus were not included 579 
among the reference genomes used for probe design. SeqCap EZ hybridization probes were 580 
designed and synthesized by Roche NimbleGen (Madison, USA) based on the resulting 581 
reference sequences. 582 
Capture was performed on double-indexed libraries prepared from ancient DNA, following 583 
the manufacturer’s protocol (version 4.3) with the following modifications. Briefly, 1.8 to 2.2 584 
µg of pooled libraries were hybridized at 47°C for 65-70 hours with low complexity C0T-1 585 
DNA, specific P5/P7 adaptor-blocking oligonucleotides each containing a hexamer motif of 586 
inosine nucleotides to match individually indexed adapters, hybridization buffer containing 587 
10% formamide, and the capture probes. Dynabeads M-270 (Invitrogen) were used to recover 588 
the hybridized library fragments. After washing and eluting the libraries, the post-capture 589 
PCR amplification was performed with KAPA Uracil+ polymerase (Kapa Biosystems). PCR 590 
cycling conditions were as follows: 1 cycle of 3 min at 95°C, followed by 14 cycles of: 20 591 
sec denaturation at 98°C, 15 sec annealing at 65°C and 30 sec elongation at 72 °C, ending 592 
with 5 min at 72°C. The amplified captured libraries were purified using AMPureXP beads 593 
(Agencourt). 594 
Shotgun sequencing data was generated as described in Allentoft et al. (2015)1. Sequencing 595 
of target-enriched libraries was performed on Illumina Hiseq2500 SR80bp, V4 chemistry.  596 
The resulting reads were compared to Dataset 2 using BLASTn (with arguments -task blastn -597 
evalue 0.01). Matching reads with bit scores greater than 50 for all samples (except DA222 598 
(70) and DA45 (55)) were selected for subsequent processing. In total, 6757 reads matched 599 
HBV after capture. 600 
Sequence authenticity 601 
The following evidence leads us to believe that the ancient HBV sequences are authentic and 602 
that the possibility of contamination can be excluded: 603 
(1)  Standard precautions for working with ancient DNA were applied46. 604 
(2)  Sequences were checked for typical ancient DNA damage patterns using 605 
mapDamage47 (version 2.0.6). Whenever sufficient amounts of data were 606 
available (>200 HBV reads), we found C>T mutations at the 5’ end, typical of 607 
ancient DNA48 (see Extended Data Fig. 1a,c). 608 
(3) Capture was performed on sample DA222 DNA extracts with and without pre-609 
treatment by Uracil-Specific Excision Reagent (USER)49. After USER treatment 610 
(3h at 37°C) of the aDNA extract, the damage pattern is eliminated (Extended 611 
Data Fig. 1b). 612 
(3)  As the ancient viruses are from three different HBV genotypes (A, B, D) and a 613 
clade in sister relationship to NHP viruses, any argument that samples were 614 
contaminated would have to account for this diversity as well as the sequence 615 
novelty. 616 
(4)  HBV sequences were identified in 25 of 305 analysed samples (Table 1), showing 617 
that the findings cannot be due to a ubiquitous laboratory contaminant. 618 
(5)  Despite the low frequency of positive samples, we sequenced extraction blanks to 619 
provide additional evidence against the possibility that the HBV sequences 620 
stemmed from sporadic incorporation, amplification, and sequencing of 621 
background reagent contaminants into the ancient DNA libraries. The negative 622 
extraction controls were amplified for 40 PCR cycles, and BLAST was used to 623 
match the read sequences against Dataset 3, with the same parameters used for the 624 
ancient samples. Because the ancient HBV positive reads used to assemble 625 
genomes all had bit scores of at least 50 (see Data and Data Processing, above), 626 
we filtered the negative extraction control BLAST output for reads with a bit 627 
score ≥45. No reads (out of 23 million) matched any HBV genome at that level. 628 
(6)  HBV is a blood-borne virus that is mainly transmitted by exposure to infectious 629 
blood and that does not occur in the environment3, making contamination during 630 
archaeological excavation extremely unlikely. 631 
Consensus sequences 632 
Reads from the original sequencing and from the capture were aligned to a reference genome 633 
(SI Table 3) in Geneious50 (version 9) using Medium Sensitivity / Fast and Iterate up to 5 634 
times. Because aDNA damage often clusters towards read termini48, the resulting alignments 635 
were carefully curated by hand to remove non-matching termini of reads if the majority of the 636 
read showed a very good match with the reference sequence. 637 
Genotyping 638 
All reads used to construct the ancient HBV consensus sequences were matched against the 639 
full NCBI nucleotide (nt) database (downloaded December 28, 2016) using BLAST. 97.5% 640 
of the reads had HBV as their top match. All ancient consensus sequences were matched 641 
against the full HBV genomes of Dataset 4 with the Needleman-Wunsch algorithm51, as 642 
implemented in EMBOSS52 (version 6.6.0.0). For each ancient sequence, the percent 643 
sequence identity for each modern genotype and four NHP species is listed in Extended Data 644 
Table 4a. The Needleman-Wunsch algorithm was also used to calculate the pairwise 645 
sequence similarity between all ancient sequences (Extended Data Table 4b). 646 
Recombination analysis 647 
The Recombination Detection Program53, version 4 (RDP4) was used to search for evidence 648 
of recombination within the 12 ancient sequences and a selection of 15 modern human and 649 
NHP sequences (Supplementary Methods). Recombination with HBV-RISE387 as the 650 
recombinant and HBV-DA51 as one parent, was suggested at positions 1567-2256, by seven 651 
recombination methods (RDP54, GENECONV55, BootScan56, MaxChi57, Chimaera58, 652 
SiScan59, and 3Seq60) with p-values from 1.179x10-6 to 5.336x10-11 (Extended Data Table 2). 653 
The same recombination was suggested for all 4 ancient genotype A and two modern 654 
genotype A sequences. Graphical evidence of the recombination and the predicted break 655 
point distribution for sequences HBV-RISE386 and HBV-RISE387 from three methods 656 
(MaxChi, Bootscan, and RDP) is shown in Extended Data Fig. 3. 657 
Phylogenetic analysis 658 
Initial maximum likelihood phylogenies 659 
An initial Maximum Likelihood (ML) tree was generated to ascertain that the ancient 660 
sequences fall within the primate HBV clades. Dataset 1 and the ancient sequences were 661 
aligned in MAFFT61 (version 7). The ML tree was constructed using PhyML62 (version 662 
20160116), optimizing topology, branch lengths, and rates. We used a GTR substitution 663 
model, with base frequencies determined by ML, and an ML-estimated proportion of 664 
invariant sites and 100 bootstraps (Extended Data Fig. 2). Furthermore, an ML tree (Extended 665 
Data Fig. 4) was generated based on a MAFFT alignment of Dataset 2 and the ancient 666 
sequences, using the same parameters as outlined above. The final trees show nodes with 667 
support values less than 70 as polytomies. 668 
Dated coalescent phylogenies 669 
In order to check for a temporal signal in the data, a root-to-tip regression and date 670 
randomisation tests were performed. For the root-to-tip regression, input trees were 671 
calculated using Dataset 2 with the addition of a Woolly Monkey sequence (GenBank 672 
Accession Number: AF046996) as an outgroup. Three phylogenetic algorithms were used, 673 
Neighbour Joining, ML (PhyML), and Bayesian (MrBayes63 (version 3.2.5)) methods (SI 674 
Figs. 1-3). Root-to-tip distances were extracted using TempEst64 (version 1.5). For ML and 675 
Bayesian, root distances for tip taxa (in substitutions per site) were extracted from optimized 676 
tree topologies (ML and Maximum Clade Credibility trees, respectively). For NJ, root-to-tip 677 
distances were averaged over 1000 bootstrap replicates. Regression analyses were performed 678 
with Scipy65 (version 0.16.0). For the date randomisation tests, we used three different 679 
approaches to randomise tip dates: First, tip dates were randomised between all sequences in 680 
the phylogeny. Second, tip dates were randomised only among the ancient sequences 681 
presented in this paper, as well as the Korean mummy sequence (accession number 682 
JN315779). The modern sequences retained their correct ages. Third, dates were randomised 683 
within a clade. For each of the three approaches, we performed three independent 684 
randomisations. This resulted in a total of nine analyses, which were run for 100,000,000 685 
generations each, under the relaxed lognormal clock model and coalescent exponential tree 686 
prior. We also ran the same analyses under a strict clock and coalescent Bayesian skyline tree 687 
prior, which were run for 20,000,000 generations. We used a GTR substitution model with 688 
unequal base frequencies, four gamma rate categories, estimated gamma distribution of rate 689 
variation, and estimated proportion of invariant sites, as found by bModelTest66 (version 690 
1.0.4). None of the analyses using the relaxed clock converged (Estimated Sample Size (ESS) 691 
< 200). This is most likely because the mis-specification of the dates leads to an incongruence 692 
between the sequence and time information. Under the strict clock model, all runs converged, 693 
and none of the 95% HPD intervals of the tree height overlapped between the randomised 694 
and the non-randomised runs, fulfilling the criteria for evidence of a temporal signal67.  695 
Dated phylogenies were estimated using BEAST226 (version 2.4.4, prerelease). We used a 696 
MAFFT alignment of Dataset 2. Using bModelTest66, we selected a GTR substitution model 697 
with unequal base frequencies, four gamma rate categories, estimated gamma distribution of 698 
rate variation, and estimated proportion of invariant sites. Proper priors were used 699 
throughout. Path sampling, as implemented in BEAST2, was performed to select between 700 
strict or relaxed lognormal clock and a coalescent constant, exponential, or coalescent 701 
Bayesian skyline tree prior (Extended Data Table 3a). Likelihood values were compared 702 
using a Bayes factor test. According to Kass and Raftery68, a Bayes factor in the range of 3-703 
20 implies positive support, 20-150 strong support, and >150 overwhelming support. The 704 
relaxed lognormal clock model in combination with a coalescent exponential tree prior was 705 
favoured. For the final tree, a Markov chain Monte Carlo analysis was run until parameters 706 
reached an ESS > 200, sampling every 2000 generations. Convergence and mixing were 707 
assessed using Tracer69 (version 1.6). The final tree files were subsampled to contain 10,000 708 
or 10710 (for the relaxed lognormal clock, coalescent exponential tree prior) trees, with the 709 
first 25% of samples discarded as burn-in. Maximum clade credibility trees were made using 710 
TreeAnnotator26 (version 2.4.4 prerelease). 711 
 712 
In order to formally test the Out of Africa hypothesis, calibration points were tested using 713 
path sampling as implemented in BEAST2. Calibration points were constrained as follows. 714 
Split of genotypes F and H: The MRCA of all genotype F and H sequences was constrained 715 
using a uniform(13,400: 25,000) distribution, as this is the range of estimates for when the 716 
Americas were first colonized70,71. Split of subgenotype A3 in Haiti: The MRCA of FJ692598 717 
and FJ692611 was constrained using a uniform(200: 500) distribution, due to the timing of 718 
the slave trade to Haiti72. Split of C3 in Polynesia: The MRCA of X75656 and X75665 was 719 
constrained using a uniform(5,100: 12,000) distribution, due to the range of estimates for the 720 
MRCA of Polynesian populations12,73. Calibration points were tested under both a relaxed 721 
lognormal clock, coalescent exponential tree prior, and a strict clock, Bayesian skyline tree 722 
prior. 723 
 724 
Data availability 725 
The complete sequences in this study have been deposited in the European Nucleotide 726 
Archive under sample accession numbers ERS2295383-ERS2295394. 727 
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Extended Data table and figure titles and legends 836 
 837 
Extended Data Table 1 | Extended overview of samples with reads matching HBV and 838 
PCR results 839 
a, Extended overview of samples with reads matching HBV. Rows are sorted by decreasing 840 
consensus coverage. Explanation of column titles, from left to right starting from the second 841 
column: 14C age and standard deviation; Median cal BP age or estimate (in years); 842 
approximate sample age in years; site; culture or period; gender; number of sequencing 843 
reads that matched HBV using DIAMOND43; number of HBV proteins matched by those 844 
reads; number of sequencing reads that matched HBV using a BLASTn44 database built 845 
from Dataset 3 (see Methods); the number of reads from the capture that matched HBV 846 
using BLASTn (as above); the bit score cut-off above which matching reads were used to 847 
form consensus sequences; the percentage of the consensus genome covered by matching 848 
reads; average depth of coverage across the reference genome, as reported by Geneious50. 849 
When reading sample information across a row, an empty cell will be encountered when 850 
processing on that sample was concluded, either (in column 6) due to too few matching 851 
reads or (penultimate column) consensus coverage less than 50%. b, TaqMan PCR results. 852 
Four extracts from samples with HBV reads were selected for TaqMan PCR confirmation: 853 
two with a large proportion of HBV reads (DA222 and DA195), two with a small proportion of 854 
HBV reads (DA85 and DA89), and one with no HBV reads (DA351). HBV was detected in 855 
extracts from DA222 and DA195, whereas the three low- and zero-read samples were 856 
negative, as were all non-template controls. 857 
 858 
Extended Data Table 2 | Genotype A predicted recombination break points and p-859 
values 860 
a, The p-values assigned to the predicted genotype A recombination by the seven methods 861 
used by RDP453, in the order given by RDP. The number of sequences in which the 862 
recombination was predicted is always 6, corresponding to the 4 ancient and two modern 863 
genotype A sequences. b, The predicted start and end break points for each of the 6 864 
genotype A sequences. Sequences are ordered from oldest to youngest. The 99% 865 
confidence intervals for the start and end points are shown (n=15 sequences analysed in all 866 
cases), and are identical for all sequences. The predicted break points are close to the 867 
boundaries of the polymerase. For example, for the modern genotype A sequence 868 
LC074724, the polymerase is found in regions 1-1623 and 2307-3221 and the predicted 869 
break points are 1622 and 2256. If recombination formed an HBV-RISE387/6 ancestor, it is 870 
possible that the entire polymerase gene was contributed by one parent. 871 
 872 
Extended Data Table 3 | Model testing and inferred age of genotypes 873 
Models were compared using Path Sampling, as implemented in BEAST228. Likelihood 874 
values were compared using a Bayes factor test. A positive value for the Bayes factor 875 
implies support for model 1, a negative value support for model 2. According to Kass and 876 
Raftery68, a Bayes factor in the range of 3-20 implies positive support, 20-150 strong 877 
support, and >150 overwhelming support. a, Results of testing different clock models and 878 
population assumptions to be used for dated phylogenies. Positive numbers indicate support 879 
for the columns model, negative number for the rows model. b, MRCA age of individual 880 
nodes under a strict clock and Bayesian skyline tree prior or under a relaxed lognormal clock 881 
and coalescent exponential tree prior. c, Root age and substitution rates under different 882 
clock models and tree priors. d, Results of testing different calibration point hypotheses 883 
under a strict clock and Bayesian skyline tree prior or under a relaxed lognormal clock and 884 
coalescent exponential tree prior.  885 
  886 
Extended Data Table 4 | Consensus sequence identity 887 
a, Best consensus sequence identity with 14 groups of HBV full genomes. The Needleman-888 
Wunsch algorithm (as implemented in EMBOSS52) was used to globally align each sample 889 
consensus sequence against each of the 3384 full HBV genomes of Dataset 4 (see 890 
Methods). The table shows the best nucleotide (nt) similarity percentage for each sample 891 
consensus against 14 genome groups from the full set of HBV genomes. In cases where the 892 
consensus length is less than the genome length, the given figure is the percentage of 893 
identical nucleotides (nts) in the matching region, not counting any alignment gaps or 894 
ambiguous consensus nts. For each sample, the genome group with the highest identity is 895 
highlighted in bold. b, Inter-consensus sequence identity. The Needleman-Wunsch algorithm 896 
was used to globally align all sample consensus sequences against one another. The table 897 
shows the nt identity percentage for each alignment. In cases where the consensus lengths 898 
were unequal, the given figure is the percentage of identical nts in the matching region, not 899 
counting any alignment gaps or ambiguous consensus nts. 900 
 901 
Extended Data Figure 1 | Ancient DNA damage patterns 902 
The frequencies of the mismatches observed between the HBV reference sequences 903 
(Extended Data Table 1) and the reads are shown as a function of distance from the 5’ end. 904 
C>T (5’) and G>A (3’) mutations are shown in red and blue, respectively. All other possible 905 
mismatches are reported in gray. Insertions are shown in purple, deletions in green, and 906 
clippings in orange. The count of reads matching HBV for each sample is shown in 907 
parentheses. a, Damage patterns for RISE563, DA222, DA119, RISE254, DA195, DA27, 908 
DA51, RISE386, RISE387, DA29, DA45, RISE154. b, Damage patterns for DA222 without 909 
(left) and with (right) USER treatment. c, Damage patterns with 10, 20, 50, 100, 200, 500 910 
and 1000 reads, where each opaque line corresponds to one replicate set of reads. 911 
  912 
Extended Data Figure 2 | Hepadnavirus Maximum Likelihood tree 913 
Shows 26 sequences from the Orthohepadnavirus species (Dataset 1, see Methods) 914 
including the ancient HBV sequences. Ancient genotype A sequences are shown in red, 915 
ancient genotype B sequences in orange, ancient genotype D sequences in blue and novel 916 
genotype sequences in green. The tree was constructed in PhyML62, optimizing for topology, 917 
branch lengths, and rates, with 100 bootstraps (see Methods). Internal nodes with <70% 918 
bootstrap support are shown as polytomies. 919 
 920 
Extended Data Figure 3 | Genotype A recombination break point evidence 921 
RDP453 was used to analyse the set of 12 ancient sequences plus a representative set of 15 922 
modern human and NHP sequences (see Methods). The seven recombination programs 923 
used by RDP4 suggested that all genotype A sequences are recombinants, with the 924 
genotype D sequence HBV-DA51 as the minor parent and an unknown major parent. The 925 
obvious interpretation is that recombination formed an ancestor of the oldest sequences, 926 
evidence of which is still present in the less ancient and the modern representatives. The 927 
panel shows the graphical evidence and predicted recombination break point distribution for 928 
the two oldest genotype A sequences, HBV-RISE386 and HBV-RISE387, according to three 929 
of the RDP4 methods (MaxChi, Bootscan, and RDP). In all sub-plots the predicted location 930 
of the break points is shown by a dashed vertical line and the surrounding gray area shows 931 
the 99% confidence interval for the break point. Sub-plots on the same row share their Y 932 
axis and those in the same column share their X axis.  a, HBV-RISE386 analysed by 933 
MaxChi. b, HBV-RISE386 analysed by Bootscan. c, HBV-RISE386 analysed by RDP. d, 934 
HBV-RISE387 analysed by MaxChi. e, HBV-RISE387 analysed by Bootscan. f, HBV-935 
RISE387 analysed by RDP. 936 
 937 
Extended Data Figure 4 | HBV Maximum likelihood tree 938 
The sequences from Dataset 2 (see Methods) and the ancient sequences were aligned in 939 
MAFFT61. The tree was constructed in PhyML62, optimizing for topology, branch lengths, and 940 
rates, with 100 bootstraps (see Methods). Internal nodes with <70% bootstrap support are 941 
shown as polytomies. Ancient genotype A sequences are shown in red, ancient genotype B 942 
sequences in orange, ancient genotype D sequences in blue and novel genotype sequences 943 
in green. Letters on internal branches indicate the genotype. Taxon names indicate: 944 
genotype / subgenotype, GenBank accession number, age, country abbreviation of 945 
sequence origin, region of sequence origin, host species, and optional additional remarks. 946 
Note that the ML tree shows topological uncertainty (polytomies) in areas where the 947 
BEAST226 tree (Figure 2) is well resolved. This is the case for two reasons. Firstly, BEAST2 948 
always produces a fully-resolved binary topology without polytomies. Second, and more 949 
important, BEAST2 creates a time tree and uses tip dates to constrain the possible 950 
topologies under consideration. Thus BEAST2 can know that certain topologies are unlikely 951 
or impossible, whereas ML cannot and thus inherently has greater uncertainty regarding tree 952 
topology. 953 
 954 
Extended Data Figure 5 | Root-to-tip regression and date randomisation tests 955 
a, Regression of root-to-tip distances and ages performed in Scipy65. 124 branch lengths 956 
were extracted using TempEst64 from trees inferred using neighbour joining (NJ), ML, and 957 
Bayesian methods. Shaded areas show 95% confidence intervals. Slopes: 1.01E-05, 1.20E-958 
05, 4.21E-06. Correlation coefficients: 0.45 (R2=0.2), 0.36 (R2=0.13), 0.51 (R2=0.26) for 959 
ML, Bayesian, and NJ trees, respectively. b, Date randomisation tests under the strict clock 960 
model. The median and 95% HPD interval for the substitution rates are given. The rate for 961 
the correctly dated tree is shown in red. Dates were randomised within all sequences, within 962 
the ancient sequences only, and within each genotype. We performed three replicates of 963 
each. None of the 95% HPD intervals for the randomised runs overlap with the 95% HPD 964 
intervals for the correctly dated runs, suggesting the presence of a temporal signal in the 965 
data. 966 
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